OPM is a biopharmaceutical company specialized in precision medicine. OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the center of our reflection, of our unique innovative model, and our investments. For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.

A selection process has been called for a 2-years Post-doc Fellowship, titled "Multimodal single-cell analysis of cancer" in the Laboratory of RNA & Disease Data Science, Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento (Italy).

The successful candidate will be trained in supporting our researchers by designing and implementing bioinformatics pipelines on high-performance computing (HPC) clusters and cloud platforms. Activities will include training in the development of Nextflow pipelines and their seamless integration into in-house or commercial servers.

The Cantone laboratory at the Department of Molecular Medicine and Medical Biotecnology (University Federico II of Naples) is looking for a Postdoctoral candidate to join the group. The position is full-time for 1 year (renewable) to develop a project on the epigenetics of sex-bias in autoimmune diseases. To this, you will both use currently established bioinformatic pipelines and develop new ones.